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Technetium pyrophosphate myocardial
scanning in acute
myocardial infarction
A r u n k u m a r N . M e h t a , M D , * Sidney G o l d s t e i n , M D , *
D a n i e l S. M a r k s , M D , * * A l b e r t Kasenter, M A * *
a n d W i l l i a m R. Eyier, M D * *

Techneti um 99"^
pyrophosphate
(99'^TCPyP) accumulates in recently infarcted myocardium and can be detected by
external imaging techniques. This study was
performed to evaluate the ability of this
isotope to identify the presence of acute
myocardial infarction. In 82 patients admitted to a coronary care unit with chest pain of
varying etiology, scan was positive in all 13
patients with acute transmural myocardial
infarction and in 23 of 27 patients with nontransmural myocardial infarction. The scan
was negative in 37 of 42 patients without
evidence of recent infarction. Four of the
remaining five patients in this group had
unstable angina pectoris. The authors believe TCPyP myocardial scanning is an easy,
noninvasive, and highly reliable test for detection of acute myocardial infarction when
performed within seven days of the onset of
chest pain. The method has particular significance when standard diagnostic aids are
difficult to interpret. It was also extremely
helpful in substantiating the diagnosis of
nontransmural
infarction.
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nary care unit as myocardial infarct suspects
within 2-7 days of the onset of their symptoms. The patients represented a broad and
heterogenous group admitted to the coronary care unit of this 1,000-bed hospital. The
patients were collected serially over a fivemonth period between January 1 and June 1,
1974. We excluded from the study patients
who did not wish to participate in the study
and those whom it was deemed inadvisable
to move from the coronary care unit to the
Nuclear Medicine Department for imaging.
Serial daily electrocardiograms and serum
glutamic oxalacetic transaminase (SGOT),
creatinine phosphokinase (CPK), and lactic
dehydrogenase (LDF-I) levels were obtained.
Upper limits of normal in our laboratory for
SGOT are 35, for CPK 40 and for LDH180 iu.
All studies were performed usinga scintillation gammacamera. Imagingwasperformed
within 60-120 minutes after intravenous injection of 15 millicuries of 99'^Tc tagged to 5
mg of stannous pyrophosphate. Patients
were then transferred by stretcher under
medical supervision to the Nuclear Medicine Department and connected to a portable m o n i t o r d e f i b r i l l a t o r . O n l y stable
patients were selected for imaging. Neither
arrhythmia nor other obvious side effects
were observed from either injection of the
isotope or from imaging. The imaging time
was approximately 15 minutes. Images of
300,000 counts were recorded on film in
anterior, left anterior oblique and left lateral
views over approximately 30 seconds. Anatomic landmarks were readily identifiable in
most images because of the accumulation of
the isotope in the bones of the chest wall.
Standard computer processing and contrast
enhancement was done in most cases.

I HE diagnosis of acute myocardial infarction by standard electrocardiographic and
enzymatic criteria has proved difficult, if not
impossible, in certain clinical situations
such as in patients suspected of having a
nontransmural infarction, in those with left
bundle branch block, and in patients with
previous myocardial infarction. With the
exception of recently developed MB-CPK
isoenzyme, cardiac enzyme elevation is not
specific for myocardial damage and may
occur secondary to congestive heart failure,
hemolysis, liver, lung or brain damage, and
following intramuscular injections ortrauma
of cardiac resuscitation. To improve diagnostic ability in these patients, a test which
could reliably indentify the presence of infarction would be of help. In addition, more
specific diagnostic parameters are required
for evaluation of the significance of variable
ST & T wave changes and transitory enzyme
elevations in patients with chest pain with
unstable angina or nontransmural infarction,
sinceonly athin line exists between unstable
angina pectoris and the diagnosis of subendocardial infarction.
A number of investigators''"" have recently
shown that t e c h n e t i u m 99'^ stannous
pyrophosphate (99'"TcPyP) accumulates in
recently infarcted myocardium and can be
detected by external imaging techniques in
humans. Bonte et aP observed that calcium
labeled w i t h 99'^ t e c h n e t i u m stannous
pyrophosphate became localized within the
mitochondria of necrotic myocardial cells
and can be imaged with scintillation cameras. The present study was performed 1) to
evaluate the ability of this isotope to indentify the presence of acute myocardial infarction in patients admitted to a coronary care
unit with chest pain of varying etiology, and
2) to further define the presence or absence
of infarction in intermediate coronary
syndrome.

The scintigrams were graded as negative,
intermediate, and definite positive depending on the activity over the cardiac area
without knowledge of the clinical diagnosis
of the patient. The following grading was
used: Negative scans represented either no
activity (Figure 1) or faint activity in one view.
Intermediate positive represented moderate
activity in at least two views (Figure 2).

Material and methods:
Myocardial scintigrams were obtained in
82 patients who were admitted to the coro-
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Figure 1
In this negative TcPyP scan in a 69-year-old patient with aortic stenosis, note the isotope uptake in the
skeleton of the chest wall. There is no activity in the area of the heart.

Figure 2
An intermediately positive TcPyP scan with moderate activity in a 44-year-old patient with nontransmural
myocardial infarction.

Definite positive scan was represented by
localized intense activity within the myocardial boundaries (Figure 3). Among the 82
p a t i e n t s w h o had Tc 99"" s t a n n o u s
pyrophosphate myocardial scintigrams, the
average age was 58 years. There were 57
males and 25 females. The patients were
divided into three groups (See Table 1).
...j 'with cliniCroup I: consisting of patients
cal evidence of acute transmural myocardial
infarction as defined by the appearance of

new Q waves, evolving ST&T wave changes
associated with rises in CPK, LDH, and
SGOT
Group IT. consisting of patients with clinical evidence of acute nontransmural myocardial (subendocardial) infarction as
defined by the presence of prominent ST
depression and T wave inversion without
new Q waves and subsequent return of these
abnormalities to base line associated with
efther typical elevation above normal limits
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Figure 3
A definitely positive TcF^P scan with localized and intense activity projected anteriorly over the cardiac
area in a patient with acute anterior myocardial infarction. Scan was obtained four days after the onset of
symptoms.

of CPK, LDH, and SGOT or a fall in serum
CPK from high normal to low values.

There were 27 patients in Group II with
clinical evidence of acute nontransmural
myocardial infarction. Twenty-three had a
positive scan. Eighteen of these 23 patients
showed intermediate activity and the rest
showed a definite activity. Four patients in
this group had negative studies, obtained
between 4 and 7 days after the onset of
symptoms. This may have been too late to
visualize the acute changes with TcPyP in
the setting of small areas of infarction. Figures 4A and 4B represent one patient in
Group II with nontransmural infarction characterized by deep T wave inversion and a
positive scan (shown in Figure 2) with intermediate activity. Angiography demonstrated
localized hypokinesis which became normal as did EKG and scan after successful bypass surgery.

Group III: consisting of patients who did
not develop clinical, enzymatic or elect r o c a r d i o g r a p h i c e v i d e n c e of acute
infarction.

Results
There were 13 patients in Group I with
acute transmural myocardial infarction. Of
these, seven had inferior, five anterior, and
one true posterior infarction as localized by
electrocardiograms. All 13 patients in these
groups had a definitely positve scintigram.
The area of infarction on the scans correlated
well with the ECG localization of infarction
(Figure 3).

TABLE I
Technetium 99 Pyrophosphate Scintigram Correlation
In Clinical Subgroups With Acute Chest Pain
Total
patients

Definite
positive

A c u t e t r a n s m u r a l infarction

13

13

0

0

Acute n o n - t r a n s m u r a l Infarction

27

5

18

4

No acute infarction

42

1

4

37

82

19

22

41

16

Intermediate
positive

Negative
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DIAS. VOL. 177 ML
SYST. VOL. 93 ML
EJECTION FRACTION 47%

DIAS. VOL. 129 ML
SYST VOL. 34 ML
EJECTION FRACTION 74%

Figure 4A
Pre- and postoperative left ventricular angiograms of a patient with subendocardial infarction whose
myocardial scan is shown in Figure 2. Note the localized antero-apical hypokinesis which became normal
after bypass surgery, with marked improvement in the ejection fraction.

dial infarction. Thirty-seven of these patients
had negative scans. Four of the remaining
five patients with seemingly false positive

None of the 42 patients in Group III
d e v e l o p e d c l i n i c a l , e n z y m a t i c , or electrocardiographic evidense of acute myocar-
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PRE OP

HC
16533451
Age 4 4

POST OP

HC
165 33451
Age 4 4

DIAS. VOL. 129 ml
SYST VOL. 34 ml
EJECTION FRACTION 74%

DIAS. VOL. 177 ml
SYST VOL. 93 ml
EJECTION FRACTION 4 7 %

Figure 4B
Artist's drawing of views in Figure 4A

scans, clinically, had "unstable angina pectoris" with variable ST & T wave abnormalities and normal enzymes. The fifth
patient had aortic insufficiency and underwent cardiac catheterization and was found
to have normal coronary angiograms. There
was no valvular c a l c i f i c a t i o n on f l u o roscopic examination. We are unable to
explain the positive scan in this particular
patient.

Discussion
This study supports previous studies by
other groups^"" and indicates that TcPyP
myocardial scans identify transmural and
nontransmural myocardial infarction with a
high degree of sensitivity and specificity.
The optimal imaging time in our experience is between 60-120 minutes after injection of isotope. Although the images are
positive as early as 12 hours after myocardial
infarction, maximum localization seems to
occur between 24-72 hours after infarction.
Posftive images can be obtained with decreasing sensitivity up to one week following

infarction, although in some patients we
were able to obtain positive images up to
two weeks. Studies obtained between 12
hours and after seven days may be negative.
Studies in dogs by Buja^ and others have
suggested a strongtemporal and topographical relationship between the deposition of
calcium and the development of positive
ggm-p(-pyp myocardial scintigrams. Their
studies have also suggested a strong correlation between the resorption of calcium from
the area of infarction and resolution of the
positive TcPyP scintigrams. The presumed
mechanism is pyrophosphate coupling with
calcium and the deposition of this complex
in damaged myocardial cells.'
99"^TcPyP appears to be the best agent
presently available for myocardial scanning,
ft is safe and inexpensive and, since itcan be
administered intravenously, it has obvious
advantages over other agents which require
intracoronary injection. Because of its relatively short half life of approximately six
hours, scans can be repeated at 24-48 hour
intervals if deemed necessary and thus may
be able to identify extension of a myocardial
infarction, should it occur. The scan is posi-
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and have not been used in humans. Gallium
67, which accumulates in tumors and abscesses, also labels recent infarction because
of associated inflammation. It will also give a
positive scan with acute pericarditis or inflammatory disease in liver or gall bladder.
In animal experiments 99'"TcPyP has been
shown to identify infarcts larger than 5
gms."

five as early as 12 hours after myocardial
infarction, allowing an early and precise
diagnosis in patients with chest pain of
varying etiology. This isotope has been used
safely for several years for bone scanning
without any reported side e f f e c t s . T h e
uptake of 99"'TcPyP in the skeleton of the
chest wall provided good anatomic landmarks. Computer processing and contrast
enhancement improved the images in some
patients, but was not an essential part of this
study.

Fourof our patientswith "unstable angina
pectoris" had positive myocardial scans
with intermediate activity. In these patients
only nonspecific ST & T wave abnormalities
were seen with serial enzymes showing a
normal pattern. Similar observations have
been made by other authors in unstable
angina pectoris.^ TcPyP myocardial scintigraphy possibly detects small areas of myocardial necrosis occurring in some patients
with unstable angina pectoris. However, ft is
also possible that myocardial scintigraphy
may label severely and chronically ischemic, but not necessarily irreversibly
damaged, myocardial cells in such a setting.

Several isotopes have been used as indicators of myocardial perfusion and to detect ischemic infarcted myocardium. These
isotope techniques depend on failure of
ischemic or scarred myocardium to pick up
the isotope, thereby producing a negative
image. Isotopes producing negative perfusion images include 42K,' 43K,'"'-"' 129 cesium,''^ 131 cesium,''* 81 r u b i d i u m , ' ' 13
nitrogen,'* and most recently 201 thallium.'^
The disadvantage of these techniques includes failure to distinguish recent from
older infarction, poor physical characteristics, and general unavailability of the radionuclides for clinical studies. The other
major disadvantage of a negative image is
loss of sensitivity from superimposition of
" c o l d " over normal areas of myocardium as
a result of the spherical geometry of left
ventricle.

These observations support previous studies'* that indicate that 99 TcPyP scans are
positive in patients with acute transmural
and nontransmural myocardial infarction,
when scans are obtained between 12 hours
and seven days after myocardial infarction.
The location of the myocardial damage on
electrocardiogram and TcPyP scans correlated closely in acute transmural infarction,
but its exact location cannot always be
precisely determined in patients with nontransmural myocardial infarction, ft has particular significance in situations in which
standard diagnostic aids are difficult to interpret and is extremely helpful in substantiati n g the d i a g n o s i s of n o n t r a n s m u r a l
infarction. Not only has this technique been
an aid to diagnosis, but it has also added to
our clinical understanding of the process of
ischemia and infarction taking place in patients with nontransmural myocardial ischemic syndromes.

y^-ggm t e t r a c y c l i n e , ' * Tc g l u c o h e p t o nate,'^ 67 g a l l i u m , ^ " and mercury c o m pounds,'^''have been used previously for
posftive imaging of myocardial infarction.
Techniques using these isotopes have certain disadvantages. Tc tetracycline is biologically unstable and also accumulates in liver
which makes a diagnosis of inferior myocardial infarction difficult. There is also need for
a 24-hour delay between administration and
optimal imaging. Tc glucoheptonate has
been found to be less sensitive and also
accumulates in the liver. Mercury c o m pounds have a risk of renal complications
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